Pavmed inc. (PAVM)
CashFlow / TTM
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Mar'15
Net loss - before noncontrolling interest

-

-

0

-19,051

-

-

0

0

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-9,224

-5,650

0

0

0

0

Adjustments to reconcile net loss - before NCI to net cash used in operating activities
Depreciation expense

14

13

12

11

9

8

7

7

7

6

6

5

3

0

0

0

-

Stock-based compensation

1,570

1,506

1,500

1,416

1,228

1,148

1,096

1,046

1,048

0

0

0

-

-

-

-

-

Debt extinguishment loss - Senior Secured Convertible Note

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense added to principal of Senior Secured Note

-

-

-

-

591

0

0

0

-

-

-

-

-

-

-

-

-

Interest expense added to principal of Senior Secured Note

-

-

-

-

-

-

-

-

188

0

0

0

-

-

-

-

-

Interest expense - amortization of debt discount - Senior Secured Note

-

-

-

-

1,606

0

0

0

-

-

-

-

-

-

-

-

-

Change in fair value - Senior Secured Convertible Note

558

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of discount - Senior Secured Note

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

Series A and Series A-1 Exchange Offer - March 15, 2018

-

-

-

-

-

-

0

0

-

0

0

0

-

-

-

-

-

Loss - Series A Preferred Stock Units private placement

-

-

-

-

-

-

-

-

3,124

0

0

0

-

-

-

-

-

Change in fair value - Series A Warrants derivative liability

-

-

-

-

96

-2,526

-311

-1,059

-1,942

0

0

0

-

-

-

-

-

Change in fair value - Series A Convertible Preferred Stock conversion option derivative liability

-

-

-

-

-64

-784

-200

-484

-643

0

0

0

-

-

-

-

-

Expense attributable to contributed services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Changes in operating assets and liabilities:
Prepaid fee to related party

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

Prepaid fees to related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Prepaid expenses and other current assets

90

137

7

15

149

16

-34

-28

-67

-74

8

75

146

0

0

0

0

Accounts payable

613

162

127

615

872

645

-354

-165

-83

381

1,436

671

877

0

0

0

0

Accrued expenses and other current liabilities

56

-197

53

87

623

381

273

85

575

121

206

-272

-286

0

0

0

0

Net cash flows used in operating activities

-13,357

-12,286

-11,274

-10,457

-8,787

0

0

0

-

-

-

-

-

-

-

-

-

Cash flows from investing activities
Net cash flows used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-5,761

-4,454

0

0

0

0

Purchase of equipment

27

0

0

0

-

-

-

-

5

5

12

14

21

0

0

0

-

Net cash flows used in investing activities

-27

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash flows from financing activities
Payment - offering costs - underwritten public offering

-

-

-

-

-

0

0

0

-

-

-

0

-

-

-

-

-

Proceeds - issue of common stock in an underwritten public offering

-

-

-

-

4,388

0

0

0

-

-

-

0

-

-

-

-

-

Net cash flows used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-14

-21

0

0

0

0

Payment - issue of Senior Convertible Note

85

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds - issue of Series A Preferred Stock Units private placement

-

-

-

-

-

-

-

-

2,537

0

0

0

-

-

-

-

-

Payment - offering costs - Series A Preferred Stock Units private placement

-

-

-

-

-

-

-

-

388

388

388

388

0

0

0

0

0

Proceeds - issue of common stock upon exercise of warrants, net

-

-

-

-

20

31

90

90

71

0

0

0

-

-

-

-

-

Net cash flows provided by financing activities

11,381

7,170

7,096

11,046

15,501

0

0

0

-

-

-

-

-

-

-

-

-

Net cash flows provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

6,445

4,295

0

0

0

0

Net (decrease) increase in cash

-

-

-

559

-

-

-

2,725

949

1,322

-2,940

669

-181

0

0

0

0